Preliminary scientific tests suggest conolidine might inhibit particular ion channels, lowering neuronal excitability and restricting soreness indicators. This system is especially suitable in neuropathic pain, in which abnormal signaling causes persistent soreness. Furthermore, conolidine seems to affect G protein-coupled receptor (GPCR) pathways